Jul 29, 2025 09:02AM
Jul 22, 2025 09:03AM
Jul 16, 2025 09:23AM
Jul 10, 2025 09:26AM
Jul 2, 2025 09:01AM
Jun 30, 2025 09:02AM
Jun 16, 2025 08:02AM Windtree Therapeutics (WINT) Announces Publication of Istaroxime Positive Phase 2 SEISMiC B Study
Jun 11, 2025 09:01AM
Jun 10, 2025 08:01AM
Jun 9, 2025 08:15AM
Jun 3, 2025 04:07PM
May 6, 2025 08:19AM
Mar 24, 2025 08:01AM
Mar 20, 2025 08:02AM Windtree Therapeutics, Inc. (WINT) Announces License and Supply Agreement to Become Sourcing Partner for a Small Biotech with an FDA Approved Product
Mar 4, 2025 08:03AM
Feb 18, 2025 08:01AM
Feb 12, 2025 08:05AM
Jan 13, 2025 08:01AM
Jan 8, 2025 08:01AM
Nov 14, 2024 08:00AM
Oct 23, 2024 08:05AM Windtree Therapeutics (WINT) Announces Istaroxime Cardiogenic Shock Patent Filings In Countries Around the World
Oct 17, 2024 08:16AM
Oct 9, 2024 08:01AM
Sep 30, 2024 08:15AM
Sep 25, 2024 08:15AM
Aug 20, 2024 04:32PM
Aug 14, 2024 04:05PM
Jul 9, 2024 06:57AM Windtree Therapeutics (WINT) PT Raised to $7 at H.C. Wainwright

341,965 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All